UK Companies House feature
PEPTONE LTD
Cash
£4M
-78.1% vs 2023
Net assets
£8M
-57% vs 2023
Employees
40
+29% vs 2023
Profit before tax
—
Period ending 2024-12-31
Profile
- Company number
- 11296080
- Status
- Active
- Incorporation
- 2018-04-06
- Last accounts made up
- 2024-12-31
- Account category
- GROUP
- Primary SIC
- 21100
- Hubs
- UK Healthcare
Net assets
9-year trend · vs UK Healthcare median
Accounts
9-year trend · latest 2024-12-31
| Metric | Trend | 2020-04-30 | 2021-04-30 | 2021-05-01 | 2021-12-31 | 2022-01-01 | 2022-12-31 | 2023-01-01 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | — | — | — | — | — | |
| Operating profit | — | — | — | — | — | — | — | — | — | |
| Profit before tax | — | — | — | — | — | — | — | — | — | |
| Net profit | — | — | — | -£492,254 | — | -£3,782,687 | — | -£8,097,606 | -£11,181,807 | |
| Cash | £39,439 | £1,383,518 | — | £808,907 | — | £5,309,135 | — | £16,729,898 | £3,655,949 | |
| Total assets less current liabilities | — | — | — | — | — | — | — | — | — | |
| Net assets | £21,705 | £1,567,498 | — | — | — | £8,708,176 | — | £19,617,694 | £8,435,889 | |
| Equity | — | — | £1,567,498 | £1,075,244 | £1,075,244 | £8,708,176 | £8,708,176 | £19,617,694 | £8,435,889 | |
| Average employees | 2 | 5 | — | 6 | — | — | — | 31 | 40 | |
| Wages | — | — | — | — | — | — | — | — | — |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102 §1A
- Reporting scope
- Consolidated (group)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Audit opinion
- Unaudited (audit-exempt)
- Going concern
- Affirmed
“The accounts have continued to be prepared on a going concern basis and the directors deem this appropriate. The company does not consider that a material uncertainty about its going concern status currently exists. In making this assessment the directors have considered the likely trading conditions for a period of twelve months from the date of our approval of these accounts.”
Subsidiaries
- Peptone Switzerland AG · 1% held · Switzerland
Significant events
- “A convertible loan note of $15.1m was raised in March 2025. This will convert on the raise of a Series B investment which was ongoing at the signing of the accounts.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
7 active · 2 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| ALLEN, Andrew, Dr | Director | 2025-06-25 | May 1966 | American |
| GOLUMBESKI, George Stanley, Dr | Director | 2022-10-06 | Apr 1957 | American |
| HEDIN, Andrew David, Mr. | Director | 2022-04-08 | Mar 1985 | American |
| KANJI, Hussein | Director | 2020-11-18 | Oct 1976 | American |
| KIENER, Peter, Dr | Director | 2023-07-04 | Apr 1952 | English,American |
| PASTEUR, Alexander Thomas, Mr. | Director | 2022-04-08 | Dec 1970 | British |
| TAMIOLA, Kamil, Dr | Director | 2018-04-06 | Dec 1982 | Polish |
Show 2 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| HEBERLING, Matthew Michael, Dr | Director | 2018-04-06 | 2023-08-03 |
| OWENS, Benjamin Michael Joseph, Dr | Director | 2023-08-10 | 2024-10-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Dr Kamil Tamiola | Individual | Shares 25–50% | 2018-04-06 | Ceased 2022-04-14 |
| Dr Matthew Michael Heberling | Individual | Shares 25–50% | 2018-04-06 | Ceased 2022-04-14 |
Filing timeline
Last 20 of 92 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-04-07 | AD01 | address | change registered office address company with date old address new address |
| 2026-04-01 | AD01 | address | change registered office address company with date old address new address |
| 2026-01-07 | RESOLUTIONS | resolution | resolution |
| 2026-01-07 | SH10 | capital | capital variation of rights attached to shares |
| 2026-01-07 | SH08 | capital | capital name of class of shares |
| 2025-11-14 | CH01 | officers | change person director company with change date |
| 2025-10-27 | CH01 | officers | change person director company with change date |
| 2025-10-08 | CS01 | confirmation-statement | confirmation statement with updates |
| 2025-10-06 | SH01 | capital | capital allotment shares |
| 2025-08-15 | AA | accounts | accounts with accounts type group |
| 2025-06-27 | AP01 | officers | appoint person director company with name date |
| 2025-05-27 | SH01 | capital | capital allotment shares |
| 2025-03-13 | RESOLUTIONS | resolution | resolution |
| 2025-03-11 | SH01 | capital | capital allotment shares |
| 2025-02-17 | SH01 | capital | capital allotment shares |
| 2024-12-13 | SH01 | capital | capital allotment shares |
| 2024-10-17 | SH01 | capital | capital allotment shares |
| 2024-10-01 | CS01 | confirmation-statement | confirmation statement with updates |
| 2024-10-01 | SH01 | capital | capital allotment shares |
| 2024-10-01 | TM01 | officers | termination director company with name termination date |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory